Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Kamada Ltd as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +2 vs. Q2 2023
- Shares held
- 5.75M
- −168.5K (−2.8%) vs. Q2 2023
- Total value
- $30.8M
- −$233.8K (−0.8%) vs. Q2 2023
- New holders
- 6
- 6 more added
- Sold out
- 4
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KMDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 51 | $36.7M |
| Q1 2026 | 43 | $38.1M |
| Q4 2025 | 46 | $33.7M |
| Q3 2025 | 46 | $37.2M |
| Q2 2025 | 39 | $40.1M |
| Q1 2025 | 35 | $34.4M |
| Q4 2024 | 23 | $37.2M |
| Q3 2024 | 30 | $34.8M |
| Q2 2024 | 30 | $31.7M |
| Q1 2024 | 28 | $31.9M |
| Q4 2023 | 29 | $36.9M |
| Q3 2023 | 25 | $30.8M |
| Q2 2023 | 23 | $31.0M |
| Q1 2023 | 23 | $28.1M |
| Q4 2022 | 28 | $23.2M |
| Q3 2022 | 32 | $31.4M |
| Q2 2022 | 35 | $32.8M |
| Q1 2022 | 37 | $37.1M |
| Q4 2021 | 46 | $43.6M |
| Q3 2021 | 47 | $40.7M |
| Q2 2021 | 53 | $45.4M |
| Q1 2021 | 41 | $44.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Kamada Ltd; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 1 | $5 | 0.00% | +1 | New |
| Advisor Group Holdings, Inc. | 100 | $534 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 251 | $1.34K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 357 | $1.91K | 0.00% | +353+8,825.0% | Added |
| Barclays PLC | 926 | $4.95K | 0.00% | +926 | New |
| Royal Bank of Canada | 1,597 | $9.00K | 0.00% | +1,377+625.9% | Added |
| UBS Group AG | 2,338 | $12.5K | 0.00% | +2,338 | New |
| State of Tennessee, Treasury Department | 7,147 | $38.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,053 | $53.7K | 0.00% | +128+1.3% | Added |
| BlackRock Inc. | 10,633 | $56.8K | 0.00% | +10,633 | New |
| Goldman Sachs Group Inc | 10,873 | $58.1K | 0.00% | −1,306−10.7% | Reduced |
| Y.D. More Investments Ltd | 14,002 | $74.8K | 0.02% | +14,002 | New |
| Citadel Advisors LLC | 25,213 | $134.6K | 0.00% | +780+3.2% | Added |
| Geode Capital Management, LLC | 25,878 | $138.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 28,950 | $154.6K | 0.00% | −31,623−52.2% | Reduced |
| Metis Global Partners, LLC | 33,001 | $177.5K | 0.01% | 00.0% | Unchanged |
| Norges Bank | 33,595 | $181.1K | 0.00% | 00.0% | Unchanged |
| Aristides Capital LLC | 40,000 | $213.6K | 0.14% | +40,000 | New |
| Meitav Dash Investments Ltd | 76,835 | $412.3K | 0.01% | −54,267−41.4% | Reduced |
| Altshuler Shaham Ltd | 265,265 | $1.42M | 0.04% | −33,232−11.1% | Reduced |
| Acadian Asset Management LLC | 523,822 | $2.82M | 0.01% | −42,417−7.5% | Reduced |
| Wells Fargo & Company | 649,616 | $3.50M | 0.00% | +4,198+0.7% | Added |
| Renaissance Technologies LLC | 866,505 | $4.63M | 0.01% | −5,000−0.6% | Reduced |
| Vanguard Group Inc | 1,021,668 | $5.46M | 0.00% | +14,625+1.5% | Added |
| Phoenix Holdings Ltd. | 2,105,523 | $11.2M | 0.21% | 00.0% | Unchanged |
| Calton & Associates, Inc. | 0 | $0 | 0.00% | −19,630−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −15,826−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −49,391−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −5,181−100.0% | Sold out |